Members of the Smad protein family function as signal transducers of the transforming growth factor (TGF-beta) superfamily proteins. The human Smad5 protein, a signal transducer downstream of TGF-beta/BMP receptors, is composed of N-terminal DNA binding domain (MH1) and C-terminal protein-protein interaction domain (MH2) connected together by a linker motif. We used homology-modeling techniques to generate a reliable molecular model of the Smad5 MH1 domain based on the crystal structure of Smad3 MH1 domain. Our study presents the structural features of a BMP-regulated, R-Smad subfamily member (consisting of Smad1, Smad5 and Smad8) for the first time. This model provides a structural basis for explaining both functional similarities and differences between Smad3 and Smad5. Also, the structural model of this molecular target would be useful for structure-based inhibitor design because of its high accuracy. The results of our study provide important insights into understanding the structure-function relationship of the members of the Smad protein family and can serve to guide future genetic and biochemical experiments in this area.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jmgm.2005.09.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SMAD5 as a novel gene for familial pulmonary arterial hypertension.
Clin Sci (Lond)
January 2025
Center for Pulmonary Hypertension, Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital, Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Article Synopsis
- A study on 325 pulmonary arterial hypertension (PAH) patients found mutations in 23% using a specific gene panel targeting 18 known PAH genes.
- Additional sequencing identified two variants in the SMAD5 gene, which were further characterized through various functional tests, confirming their expression and effects on cell behavior.
- One variant was linked to a familial history of PAH and resulted in increased cell viability, while the other variant, associated with congenital heart disease, led to reduced cell viability due to increased apoptosis; both were deemed likely pathogenic and indicate SMAD5 as a potential new PAH gene for diagnostic testing.
Transcription factor SMAD5 upregulates ALG5 to alleviate osteoporosis development by inducing osteogenic differentiation.
J Orthop
March 2025
Department of Spine Surgery, Shanghai Changzheng Hospital, Naval Medical University, 200003, Shanghai City, China.
Background: Impaired osteogenic differentiation ability of mesenchymal stem cells (MSCs) plays a pathogenic role in osteoporosis (OP). ALG5, a key glucosyltransferase, participates in the synthesis of the glucose-residue donor. However, little is known about the role of ALG5 in OP pathogenesis and osteogenic differentiation.
View Article and Find Full Text PDFExploring Smad5: a review to pave the way for a deeper understanding of the pathobiology of common respiratory diseases.
Mol Med
November 2024
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Article Synopsis
- Smad5 is a key protein in the bone morphogenetic protein (BMP) signaling pathway, influencing various functions in respiratory diseases while its individual roles have been underexplored.
- This review focuses on Smad5's gene characteristics, protein structure, localization, and involvement in diseases like COPD, asthma, PAH, lung cancer, and IPF—with emphasis on cell behavior like proliferation and apoptosis.
- The paper highlights Smad5's unique nuclear-cytoplasmic shuttling abilities, which may be significant in understanding its role in the development and progression of respiratory diseases.
Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.
Proc Natl Acad Sci U S A
November 2024
Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030.
Activin receptor type 1 (ACVR1; ALK2) and activin receptor like type 1 (ACVRL1; ALK1) are transforming growth factor beta family receptors that integrate extracellular signals of bone morphogenic proteins (BMPs) and activins into Mothers Against Decapentaplegic homolog 1/5 (SMAD1/SMAD5) signaling complexes. Several activating mutations in ALK2 are implicated in fibrodysplasia ossificans progressiva (FOP), diffuse intrinsic pontine gliomas, and ependymomas. The ALK2 R206H mutation is also present in a subset of endometrial tumors, melanomas, non-small lung cancers, and colorectal cancers, and ALK2 expression is elevated in pancreatic cancer.
View Article and Find Full Text PDFBMP5 promotes trophoblast functions upon N-glycosylation via the BMP5-SMAD1/5 signaling pathway in preeclampsia.
Placenta
December 2024
Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Electronic address:
Article Synopsis
- Preeclampsia (PE) is a common pregnancy complication with unclear causes, and BMP5, a glycoprotein in the placenta, may play a crucial role in trophoblast cell function.
- The study found that BMP5 expression and its N-glycosylation are lower in preeclamptic tissues, suggesting that changes in BMP5 may affect cell behaviors like proliferation and invasion.
- Ultimately, the research indicates that N-glycosylated BMP5 enhances trophoblastic functions through the BMP5-SMAD1/5 signaling pathway, offering new insights for diagnosing and treating preeclampsia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!